The study reported
a total fetal loss of 1.7% in the amniocentesis group compared with
0.7% in the control group [5]. Recent large collaborative trials have
demonstrated a lower risk of mid-trimester genetic amniocentesis
with a procedure-related fetal loss rate of only 0.06% to 0.86%
[2,6–13]; furthermore,